Research ArticleExperimental Studies
Pseudogene KRT17P3 Promotes NSCLC Progression Through Mir-338-3p/USP7/C-Myc
LIPING WEI, ZHAOYAN JIANG, SHUJUAN CHEN, NING XIA, JIEJUN KONG, YAN CHANG and ZHIBO HOU
Anticancer Research December 2024, 44 (12) 5405-5423; DOI: https://doi.org/10.21873/anticanres.17367
LIPING WEI
1China State Institute of Pharmaceutical Industry, Shanghai, P.R. China;
ZHAOYAN JIANG
2Department of Anatomy, Histology and Embryology, Nanjing Medical University, Nanjing, P.R. China;
SHUJUAN CHEN
3Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing, P.R. China;
4Department of Respiratory Medicine, Nanjing Chest Hospital, Nanjing, P.R. China;
NING XIA
3Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing, P.R. China;
4Department of Respiratory Medicine, Nanjing Chest Hospital, Nanjing, P.R. China;
JIEJUN KONG
3Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing, P.R. China;
5Department of Radiology, Nanjing Chest Hospital, Nanjing, P.R. China
YAN CHANG
1China State Institute of Pharmaceutical Industry, Shanghai, P.R. China;
ZHIBO HOU
3Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing, P.R. China;
4Department of Respiratory Medicine, Nanjing Chest Hospital, Nanjing, P.R. China;

Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
patientACCESS
patientACCESS - Patients desiring access to articles
In this issue
Pseudogene KRT17P3 Promotes NSCLC Progression Through Mir-338-3p/USP7/C-Myc
LIPING WEI, ZHAOYAN JIANG, SHUJUAN CHEN, NING XIA, JIEJUN KONG, YAN CHANG, ZHIBO HOU
Anticancer Research Dec 2024, 44 (12) 5405-5423; DOI: 10.21873/anticanres.17367
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.